Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
Department of Health and Human Services
NIMH requires an experimental therapeutics approach for the development and testing of therapeutic interventions, in which studies both evaluate the clinical effect of an intervention and generate information about the mechanisms underlying a disorder or an intervention response. As part of NIMHs Clinical Trial Pipeline, this NOFO encourages early stage testing of pharmacologic interventions with novel mechanisms of actions or device-based interventions. More specifically, this NOFO is intended to support early stage testing of pharmacologic or device-based interventions using a protocol design where the presumed mechanism of action of the intervention is adequately tested, to provide meanin
Funding
Award size
Not specified
Type
Grant
Dates
Deadline
Later
Posted
11/26/2024
Closes
2027-10-15
Eligibility
Eligibility
Independent school districtsCounty governmentsOthers (see text field entitled "Additional Information on Eligibility" for clarification)For profit organizations other than small businessesNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationSpecial district governmentsNative American tribal governments (Federally recognized)Native American tribal organizations (other than Federally recognized tribal governments)Public and State controlled institutions of higher educationState governmentsCity or township governmentsPublic housing authorities/Indian housing authoritiesSmall businessesNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher education
Program
Funding area
Health - HL
Opportunity #
PAR-25-183
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov